Chemoinformaics analysis of (+)-Catechin-7-L-Arabinoside
| Molecular Weight | 422.386 | nRot | 4 |
| Heavy Atom Molecular Weight | 400.21 | nRig | 22 |
| Exact Molecular Weight | 422.121 | nRing | 4 |
| Solubility: LogS | -3.229 | nHRing | 2 |
| Solubility: LogP | -0.441 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 52 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 10 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 22 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 12 |
| nHA | 10 | APOL | 56.0894 |
| nHD | 7 | BPOL | 27.2786 |
| QED | 0.324 |
| Synth | 4.139 |
| Natural Product Likeliness | 2.482 |
| NR-PPAR-gamma | 0.828 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.089 |
| HIA | 0.802 |
| CACO-2 | -6.47 |
| MDCK | 0.0000147 |
| BBB | 0.344 |
| PPB | 0.902053 |
| VDSS | 0.718 |
| FU | 0.136903 |
| CYP1A2-inh | 0.023 |
| CYP1A2-sub | 0.056 |
| CYP2c19-inh | 0.011 |
| CYP2c19-sub | 0.068 |
| CYP2c9-inh | 0.004 |
| CYP2c9-sub | 0.399 |
| CYP2d6-inh | 0.031 |
| CYP2d6-sub | 0.23 |
| CYP3a4-inh | 0.034 |
| CYP3a4-sub | 0.077 |
| CL | 9.467 |
| T12 | 0.509 |
| hERG | 0.011 |
| Ames | 0.465 |
| ROA | 0.128 |
| SkinSen | 0.499 |
| Carcinogencity | 0.761 |
| EI | 0.049 |
| Respiratory | 0.036 |
| NR-Aromatase | 0.797 |
| Antiviral | Yes |
| Prediction | 0.671189 |